BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36151945)

  • 1. Satisfaction and access to care for adults and adolescents with sickle cell disease: ASCQ-Me quality of care and the SHIP-HU study.
    Sisler I; McClish DK; Valrie C; Villella A; Smith WR
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29948. PubMed ID: 36151945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.
    Keller S; Yang M; Treadwell MJ; Hassell KL
    Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care.
    Evensen CT; Treadwell MJ; Keller S; Levine R; Hassell KL; Werner EM; Smith WR
    Medicine (Baltimore); 2016 Aug; 95(35):e4528. PubMed ID: 27583862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.
    Kanter J; Gibson R; Lawrence RH; Smeltzer MP; Pugh NL; Glassberg J; Masese RV; King AA; Calhoun C; Hankins JS; Treadwell M
    JAMA Netw Open; 2020 May; 3(5):e206016. PubMed ID: 32469413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of community health workers on quality of life in adolescents and young adults with sickle cell disease: The SHIP-HU study.
    Sisler I; McClish DK; Villella A; Valrie C; Smith WR
    Br J Haematol; 2024 Feb; 204(2):649-657. PubMed ID: 37779237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea for the treatment of sickle cell disease.
    Segal JB; Strouse JJ; Beach MC; Haywood C; Witkop C; Park H; Wilson RF; Bass EB; Lanzkron S
    Evid Rep Technol Assess (Full Rep); 2008 Mar; (165):1-95. PubMed ID: 18457478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents.
    Reddy PS; Cai SW; Barrera L; King K; Badawy SM
    Ann Med; 2022 Dec; 54(1):683-693. PubMed ID: 35234095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
    Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.
    Keller SD; Yang M; Treadwell MJ; Werner EM; Hassell KL
    Health Qual Life Outcomes; 2014 Aug; 12():125. PubMed ID: 25146160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study.
    Aisiku IP; Penberthy LT; Smith WR; Bovbjerg VE; McClish DK; Levenson JL; Roberts JD; Roseff SD
    J Natl Med Assoc; 2007 Aug; 99(8):886-90. PubMed ID: 17722665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perception to hydroxyurea therapy in patients with sickle cell disease: Report from 3 centers.
    Korubo KI; Onodingene NM; Okoye HC; Omunakwe HE
    Ann Afr Med; 2021; 20(2):127-131. PubMed ID: 34213480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
    Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
    JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
    Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease in Grenada: Quality of life and barriers to care.
    Grygiel A; Ikolo F; Stephen R; Bleasdille D; Robbins-Furman P; Nelson B; Sobering AK; Elsea SH
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1567. PubMed ID: 33332776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
    Smaldone A; Findley S; Bakken S; Matiz LA; Rosenthal SL; Jia H; Matos S; Manwani D; Green NS
    Contemp Clin Trials; 2016 Jul; 49():134-42. PubMed ID: 27327779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Patient-Physician Communication on the Use of Hydroxyurea in Adult Patients with Sickle Cell Disease.
    Jabour SM; Beachy S; Coburn S; Lanzkron S; Eakin MN
    J Racial Ethn Health Disparities; 2019 Dec; 6(6):1233-1243. PubMed ID: 31410784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol.
    Smaldone A; Manwani D; Aygun B; Smith-Whitley K; Jia H; Bruzzese JM; Findley S; Massei J; Green NS
    BMC Pediatr; 2019 Oct; 19(1):354. PubMed ID: 31615480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.